|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/395 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2877493 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13745296.7 |
| Europos patento paraiškos padavimo data | 2013-07-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-06-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-03-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/051815 |
| Data | 2013-07-24 |
| (87) | Numeris | WO 2014/018625 |
| Data | 2014-01-30 |
| (30) | Numeris | Data | Šalis |
| 201261675751 P | 2012-07-25 | US | |
| 201261675762 P | 2012-07-25 | US |
| (72) |
HADARI, Yaron, US
MANDEL-BAUSCH, Elizabeth, M., US
CARR, Francis, Joseph, GB
JONES, Timothy, David, GB
PERRY, Laura, Clare Alexandra, GB
|
| (73) |
Celldex Therapeutics, Inc.,
53 Frontage Road, Suite 200, Hampton, NJ 08827,
US
|
| (54) | ANTI-KIT ANTIBODIES AND USES THEREOF |
| ANTI-KIT ANTIBODIES AND USES THEREOF |